Evidence map›Paper›PMID 24587671›Full record

ReviewWorld journal of gastroenterology2014

Colorectal cancer and lymph nodes: the obsession with the number 12.

Giovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo

2 registry-linked trialsAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05667259 completednot on this map

Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival: An Alternative Not a Substitute

TypeobservationalSponsorSouth Valley UniversityRan2012 to 2022Enrolled229ConditionsCancer, RectumArmsSurgical resection for cancer rectum
NCT06096493 unknown statusnot on this mapstarted 2023, after this paper: background citation

Predictors of Disease Free Survival After Curative Cancer Rectum Surgery

TypeobservationalSponsorSouth Valley UniversityRan2023 to 2023Enrolled200ConditionsRectal CancerArmscurative surgery for cancer rectum
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Feasibility of indocyanine green (ICG) fluorescence inPathology oncology research : POR · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giovanni Li DestriGiovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, 95123 Catania, Italy.
Isidoro Di CarloGiovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, 95123 Catania, Italy.
Roberto ScillettaGiovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, 95123 Catania, Italy.
Beniamino ScillettaGiovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, 95123 Catania, Italy.
Stefano PuleoGiovanni Li Destri, Isidoro Di Carlo, Roberto Scilletta, Beniamino Scilletta, Stefano Puleo, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, 95123 Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphadenectomy of colorectal cancer is a decisive factor for the prognostic and therapeutic staging of the patient. For over 15 years, we have asked ourselves if the minimum number of 12 examined lymph nodes (LNs) was sufficient for the prevention of understaging. The debate is certainly still open if we consider that a limit of 12 LNs is still not the gold standard mainly because the research methodology of the first studies has been criticized. Moreover many authors report that to date both in the United States and Europe the number "12" target is uncommon, not adequate, or accessible only in highly specialised centres. It should however be noted that both the pressing nature of the debate and the dissemination of guidelines have been responsible for a trend that has allowed for a general increase in the number of LNs examined. There are different variables that can affect the retrieval of LNs. Some, like the surgeon, the surgery, and the pathology exam, are without question modifiable; however, other both patient and disease-related variables are non-modifiable and pose the question of whether the minimum number of examined LNs must be individually assigned. The lymph nodal ratio, the sentinel LNs and the study of the biological aspects of the tumor could find valid application in this field in the near future.

Indexed as

Lymph Node ExcisionColorectal NeoplasmsEuropeHumansLaparoscopyLymphatic MetastasisLymph NodesNeoplasm StagingPrognosisTreatment OutcomeUnited StatesColorectal cancerLymphadenectomyLymph node countLymph node ratioStaging

Identifiers

PMID24587671
PMCPMC3934465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.